-
公开(公告)号:US20050261261A1
公开(公告)日:2005-11-24
申请号:US11051460
申请日:2005-02-07
申请人: Kathleen Barton , Thomas Borchardt , Marlon Carlos , Subhash Desai , Leonard Ferro , Henry Gaud , Scott Ganser , Clay Little , Partha Mudipalli , Mark Pietz , Daniel Pilipauskas , Yuen-Lung Sing , Glenn Stahl , Joseph Wieczorek , Chris Yan
发明人: Kathleen Barton , Thomas Borchardt , Marlon Carlos , Subhash Desai , Leonard Ferro , Henry Gaud , Scott Ganser , Clay Little , Partha Mudipalli , Mark Pietz , Daniel Pilipauskas , Yuen-Lung Sing , Glenn Stahl , Joseph Wieczorek , Chris Yan
CPC分类号: C07J71/00 , C07J71/0015
摘要: A novel crystalline form (Form L) of the aldosterone receptor antagonist drug eplerenone is provided having relatively high physical stability at normal temperatures of storage and use. Pharmaceutical compositions are also provided comprising Form L eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form L eplerenone and for preparing compositions comprising Form L eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form L eplerenone.
摘要翻译: 提供醛固酮受体拮抗剂药物依普利酮的新型结晶形式(形式L),其在常规储存和使用温度下具有相对较高的物理稳定性。 还提供药物组合物,其包含任选伴随有一种或多种其它固体形式的依普利酮的甲基泼尼龙,总单位剂量为约10至约1000mg的依普利酮,并且还包含一种或多种药学上可接受的赋形剂。 提供了用于制备L-赖康孕酮的方法和用于制备包含L-赖普肾素的组合物。 还提供了一种用于预防和/或治疗醛固酮介导的病症或病症的方法,其包括向受试者施用治疗有效量的依普利酮,其中至少一部分所述的依普利酮是勃立普仑。
-
2.
公开(公告)号:US20050267302A1
公开(公告)日:2005-12-01
申请号:US10727681
申请日:2003-12-04
申请人: Kathleen Barton , Thomas Borchardt , Marlon Carlos , Subhash Desai , Leonard Ferro , Henry Gaud , Scott Ganser , Clay Little , Partha Mudipalli , Mark Pietz , Daniel Pilipauskas , Yuen-Lung Sing , Glenn Stahl , Joseph Wieczorek , Chris Yan
发明人: Kathleen Barton , Thomas Borchardt , Marlon Carlos , Subhash Desai , Leonard Ferro , Henry Gaud , Scott Ganser , Clay Little , Partha Mudipalli , Mark Pietz , Daniel Pilipauskas , Yuen-Lung Sing , Glenn Stahl , Joseph Wieczorek , Chris Yan
IPC分类号: C07J21/00
CPC分类号: C07J21/00
摘要: A novel crystalline form (Form H) of the aldosterone receptor antagonist drug eplerenone is provided having a relatively rapid dissolution rate in aqueous media. Also provided are novel solvated crystalline forms of eplerenone that, when desolvated, can yield Form H eplerenone. Also provided is amorphous eplerenone. Pharmaceutical compositions are provided comprising Form H eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form H eplerenone and for preparing compositions comprising Form H eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form H eplerenone.
摘要翻译: 提供醛固酮受体拮抗剂药物依普利酮的新型结晶形式(形式H),其在水性介质中具有相对快速的溶解速率。 还提供了eplerenone的新型溶剂化结晶形式,当脱溶时,可以产生H形式。 还提供了非依依普利酮。 提供了药物组合物,其包含H形式H eplerenone,任选地伴随有一种或多种其他固体形式的依普利酮,总单位剂量为约10至约1000mg的依普利酮,并且还包含一种或多种药学上可接受的赋形剂。 提供了制备H形式H eplerenone和制备包含H型肝素的组合物的方法。 还提供了用于预防和/或治疗醛固酮介导的病症或病症的方法,其包括向受试者施用治疗有效量的依普利酮,其中至少一部分所述的依普利酮是H型肾上腺素。
-
公开(公告)号:US20050159594A1
公开(公告)日:2005-07-21
申请号:US10892406
申请日:2004-07-16
申请人: Kathleen Barton , Thomas Borchardt , Marlon Carlos , Subhash Desai , Leonard Ferro , Henry Gaud , Scott Ganser , Clay Little , Partha Mudipalli , Mark Pietz , Daniel Pilipauskas , Yuen-Lung Sing , Glenn L. Stahl , Joseph Wieczorek , Chris Yan
发明人: Kathleen Barton , Thomas Borchardt , Marlon Carlos , Subhash Desai , Leonard Ferro , Henry Gaud , Scott Ganser , Clay Little , Partha Mudipalli , Mark Pietz , Daniel Pilipauskas , Yuen-Lung Sing , Glenn L. Stahl , Joseph Wieczorek , Chris Yan
IPC分类号: C07D301/12 , C07J1/00 , C07J21/00 , C07J31/00 , C07J41/00 , C07J53/00 , C07J71/00 , C12P33/00 , C12P33/10 , C12Q1/02 , A61K31/585
CPC分类号: C07J71/0015 , C07D301/12 , C07J1/0059 , C07J21/00 , C07J21/003 , C07J31/006 , C07J41/0094 , C07J53/002 , C07J71/0005 , C12P33/005 , C12P33/10 , C12Q1/02
摘要: A novel crystalline form (Form H) of the aldosterone receptor antagonist drug eplerenone is provided having a relatively rapid dissolution rate in aqueous media. Also provided are novel solvated crystalline forms of eplerenone that, when desolvated, can yield Form H eplerenone. Also provided is amorphous eplerenone. Pharmaceutical compositions are provided comprising Form H eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form H eplerenone and for preparing compositions comprising Form H eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form H eplerenone.
摘要翻译: 提供醛固酮受体拮抗剂药物依普利酮的新型结晶形式(形式H),其在水性介质中具有相对快速的溶解速率。 还提供了eplerenone的新型溶剂化结晶形式,当脱溶时,可以产生H形式。 还提供了非依依普利酮。 提供了药物组合物,其包含H形式H eplerenone,任选地伴随有一种或多种其他固体形式的依普利酮,总单位剂量为约10至约1000mg的依普利酮,并且还包含一种或多种药学上可接受的赋形剂。 提供了制备H形式H eplerenone和制备包含H型肝素的组合物的方法。 还提供了用于预防和/或治疗醛固酮介导的病症或病症的方法,其包括向受试者施用治疗有效量的依普利酮,其中至少一部分所述的依普利酮是H型肾上腺素。
-
4.
公开(公告)号:US08597017B2
公开(公告)日:2013-12-03
申请号:US12971135
申请日:2010-12-17
申请人: Troy Rubenzer , Jim Eggert , Dale Thompson , Kathleen Barton , David J. Weiss , Matt Sedivy
发明人: Troy Rubenzer , Jim Eggert , Dale Thompson , Kathleen Barton , David J. Weiss , Matt Sedivy
IPC分类号: B29C33/42
CPC分类号: F16B17/00 , B29C33/308 , B29C37/00 , B29L2031/005 , F16B11/006 , Y10T403/47 , Y10T403/471 , Y10T403/473 , Y10T403/52 , Y10T403/70 , Y10T403/7073 , Y10T428/24777
摘要: A mold for producing a variety of fenestration members having different predetermined lengths is disclosed. Generally, the mold has a first lineal mold part that has an extended length and a second lineal mold part also having an extended length. The mold may also have mold end parts that are adapted to form end features of the fenestration member. In use, the first lineal mold part and the second lineal mold part fit together to define a profile. The first and second mold end parts can be positioned in a range of positions to define the lengths of a variety of different molded fenestration members.
摘要翻译: 公开了一种用于生产具有不同预定长度的各种开窗构件的模具。 通常,模具具有延伸长度的第一直线模具部件和也具有延伸长度的第二直线模具部件。 模具还可以具有适于形成开窗构件的端部特征的模具端部。 在使用中,第一线性模具部件和第二线性模具部件配合在一起以限定型材。 第一和第二模具端部可定位在一定范围的位置以限定各种不同的模制开窗构件的长度。
-
公开(公告)号:US20060156633A1
公开(公告)日:2006-07-20
申请号:US11027681
申请日:2005-01-03
申请人: James Guhl , David Weiss , Frank Campbell , Kathleen Barton , Craig Johnson
发明人: James Guhl , David Weiss , Frank Campbell , Kathleen Barton , Craig Johnson
IPC分类号: E06B1/04
CPC分类号: B29C66/54 , B29C65/10 , B29C65/103 , B29C65/18 , B29C65/203 , B29C65/2061 , B29C65/42 , B29C65/425 , B29C65/48 , B29C65/4815 , B29C65/54 , B29C65/56 , B29C65/564 , B29C65/565 , B29C65/7841 , B29C66/0042 , B29C66/112 , B29C66/114 , B29C66/5414 , B29C66/71 , B29C66/80 , B29C66/8122 , B29C66/8242 , B29C66/8322 , B29C66/83221 , B29C66/841 , B29C66/843 , B29K2027/06 , B29L2031/778 , E06B3/20 , E06B3/44 , E06B3/4407 , E06B3/549 , B29K2827/18
摘要: A window sash is formed from a pair of one-piece injection molded sash body members having substantially the same mechanical configuration. Each sash body member has an inner, facing surface and a non-facing surface. The facing surface of each sash body member is provided with a plurality of locators of two different types, arranged about axis of anti-symmetry. The two different types of locators are complementary to one another, and so are configured to engage each other. This allows a window sash to be formed of substantially identical components that are mated together. Each sash member may be provided, on its facing surface, with a weld wall that is set back from the outer sash member edges. The window sash may be assembled after heating the weld walls and joining the two substantially identical sash members.
摘要翻译: 窗框由一对具有基本上相同的机械结构的一体式注塑成型的框体构件形成。 每个窗框本体构件具有内部的,面对的表面和不面对的表面。 每个窗框本体构件的面对表面设置有围绕反对称轴设置的两种不同类型的多个定位器。 两种不同类型的定位器彼此互补,因此被配置为彼此接合。 这允许窗框由基本上相同的组件形成,这些组件被配合在一起。 每个窗扇构件可以在其面对表面上设置有从外窗扇构件边缘设置的焊接壁。 可以在加热焊接壁并连接两个基本上相同的窗扇构件之后组装窗框。
-
6.
公开(公告)号:US20110171434A1
公开(公告)日:2011-07-14
申请号:US12971135
申请日:2010-12-17
申请人: Troy Rubenzer , Jim Eggert , Dale Thompson , Kathleen Barton , David J. Weiss , Matt Sedivy
发明人: Troy Rubenzer , Jim Eggert , Dale Thompson , Kathleen Barton , David J. Weiss , Matt Sedivy
CPC分类号: F16B17/00 , B29C33/308 , B29C37/00 , B29L2031/005 , F16B11/006 , Y10T403/47 , Y10T403/471 , Y10T403/473 , Y10T403/52 , Y10T403/70 , Y10T403/7073 , Y10T428/24777
摘要: A mold for producing a variety of fenestration members having different predetermined lengths is disclosed. Generally, the mold has a first lineal mold part that has an extended length and a second lineal mold part also having an extended length. The mold may also have mold end parts that are adapted to form end features of the fenestration member. In use, the first lineal mold part and the second lineal mold part fit together to define a profile. The first and second mold end parts can be positioned in a range of positions to define the lengths of a variety of different molded fenestration members.
摘要翻译: 公开了一种用于生产具有不同预定长度的各种开窗构件的模具。 通常,模具具有延伸长度的第一直线模具部件和也具有延伸长度的第二直线模具部件。 模具还可以具有适于形成开窗构件的端部特征的模具端部部件。 在使用中,第一线性模具部件和第二线性模具部件配合在一起以限定型材。 第一和第二模具端部可定位在一定范围的位置以限定各种不同的模制开窗构件的长度。
-
-
-
-
-